E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/26/2006 in the Prospect News Biotech Daily.

OptiMedica closes $13.8 Million series A and B financing

By Lisa Kerner

Erie, Pa., April 26 - OptiMedica Corp. said it has closed a round of $13.8 million series A and B financing.

Proceeds will be used for technology roll outs.

The financing was led by Kleiner Perkins Caufield & Byers and Alloy Ventures.

Located in Santa Clara, Calif., OptiMedica develops and markets medical devices to treat ophthalmic disorders.

Issuer:OptiMedica Corp.
Issue:Series A and B financing
Amount:$13.8 million
Investors:Kleiner Perkins Caufield & Byers and Alloy Ventures
Announcement date:April 26

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.